Skip to main content

Table 1 Comparison of migraine incidence and acute medication monthly intake of respondents in relation to the effect of COVID-19 pandemic on their disease

From: Results of a Web-based survey of 2105 Greek migraine patients in 2020: demographics, clinical characteristics, burden and the effects of the COVID-19 pandemic on the course of migraine

Groups of respondents in relation to the effect of COVID-19 pandemic on migraine burden

No effect

Worst

Better

P value

Monthly migraine frequency

  (Mean ± SD)

7.2 ± 5.8

6.9 ± 8.5

7.1 ± 5.5

P = 0.52

 Median

6

7

6

 

Monthly days with acute medication use

  (Mean ± SD)

4.7 ± 3.7

5.1 ± 5.2

4.5 ± 3.4

P = 0.22

 Median

4

5

4